Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

To share the news that she’d be starring in the biopic “Lilly,” Clarkson called her own hero – her mother. “The first person I called when I said yes to playing Lilly Ledbetter was my ...

However, the bank does believe that the sell-off of Lilly stock on the news (Lilly shares were down 12% yesterday, although part of that was due to earnings) is "overdone." In JPMorgan's view ...

Eli Lilly said the revision reflects a $1.57 billion deal charge recorded in the first quarter, which is primarily related to its acquisition of a certain oral cancer drug from Scorpion Therapeutics.

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other growth stocks to buy for the next 3 years. On April 29, Dan Ives of Wedbush Securities ...

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda from rival drugmaker Novo ...

New York Jets face a quarterback crisis. Rookie Jordan Travis retired due to a leg injury before playing. Veteran Aaron Rodgers also left the team. The Jets' quarterback depth is now thin.

Eli Lilly (NYSE: NYSE:LLY) is set to report its first-quarter earnings on Thursday, May 1st, before the market opens. Analysts expect the drugmaker to earn $3.46 (+34.1% Y/Y) on revenue of $12.72B ...

SPRINGFIELD, S.D. (KELO) — A sunny day in southern South Dakota welcomed members of Project Prison Reset’s task force to Springfield, where the group sat down and made a decision Tuesday ...

“President Trump deserves credit for an energetic and effective start,” Pence wrote, before noting how things should change this time around. News Reporter Former Vice President Mike Pence ...

Eli Lilly is paying $13 million upfront, with $1 billion in biobucks up for grabs, for the opportunity to develop AI-designed oligonucleotide therapies from Creyon Bio. Oligonucleotides work as ...

The Alzheimer’s drug, MEDI1814, is an amyloid beta mAb that had been developed in collaboration with Eli Lilly in a pact dating back nearly a decade. Lilly, which markets its AD therapy Kisunla ...